Symbols / ECOR $5.64 -3.75% electroCore, Inc.

Healthcare • Medical Devices • United States • NCM
ECOR Chart
About

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 45.59M
Enterprise Value 43.38M Income -13.97M Sales 32.03M
Book/sh -0.21 Cash/sh 1.44 Dividend Yield —
Payout 0.00% Employees 83 IPO —
P/E — Forward P/E -10.25 PEG —
P/S 1.42 P/B -26.36 P/C —
EV/EBITDA -3.43 EV/Sales 1.35 Quick Ratio 1.11
Current Ratio 1.38 Debt/Eq — LT Debt/Eq —
EPS (ttm) -1.65 EPS next Y -0.55 EPS Growth —
Revenue Growth 31.20% Earnings 2026-05-06 ROA -42.01%
ROE -4.79% ROIC — Gross Margin 86.75%
Oper. Margin -31.82% Profit Margin -43.60% Shs Outstand 8.08M
Shs Float 5.12M Short Float 3.43% Short Ratio 4.96
Short Interest — 52W High 8.64 52W Low 4.16
Beta 0.50 Avg Volume 69.10K Volume 18.16K
Target Price $19.80 Recom Strong_buy Prev Close $5.86
Price $5.64 Change -3.75%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$19.80
Mean price target
2. Current target
$5.64
Latest analyst target
3. DCF / Fair value
$-6.03
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.64
Low
$12.00
High
$25.00
Mean
$19.80

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-26 main HC Wainwright & Co. Buy → Buy $18
2025-03-13 main Ladenburg Thalmann Buy → Buy $26
2025-03-13 reit HC Wainwright & Co. Buy → Buy $25
2024-12-18 main HC Wainwright & Co. Buy → Buy $25
2024-03-14 reit HC Wainwright & Co. Buy → Buy $15
2024-01-22 main HC Wainwright & Co. Buy → Buy $15
2023-11-09 main HC Wainwright & Co. Buy → Buy $11
2023-08-10 reit HC Wainwright & Co. Buy → Buy $10
2023-05-04 main HC Wainwright & Co. — → Buy $10
2023-04-18 reit CG Capital — → Outperform $30
2023-04-18 main HC Wainwright & Co. — → Buy $8
2023-03-09 reit HC Wainwright & Co. — → Buy $7
News
RSS: Latest ECOR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-19 ERRICO THOMAS J. Director — 42,055 $4.35 $222,983
2026-01-26 GOLDBERGER DANIEL S Chief Executive Officer — 46,375 $0.00 $152,201
2026-01-26 LEV JOSHUA S. Chief Financial Officer — 27,889 $0.00 $0
2025-12-04 LEV JOSHUA S. Chief Financial Officer — 2,500 $5.05 $12,625
2025-12-02 GOLDBERGER DANIEL S Chief Executive Officer — 1,000 $4.84 $4,840
2025-11-12 LEV JOSHUA S. Chief Financial Officer — 2,166 $6.18 $13,386
2025-09-10 BONFIGLIOLI ELENA Director — 30,549 $0.00 $0
2025-09-02 GANDOLFO JOHN P Director — 19,011 $0.00 $0
2025-09-02 PATTON THOMAS M Director — 19,011 $0.00 $0
2025-09-02 ERRICO THOMAS J. Director — 26,615 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
25.18
+57.09%
16.03
+86.57%
8.59
+57.62%
5.45
Operating Revenue
25.18
+57.09%
16.03
+86.57%
8.59
+57.62%
5.45
Cost Of Revenue
3.79
+34.99%
2.80
+73.51%
1.62
+16.68%
1.39
Reconciled Cost Of Revenue
3.79
+34.99%
2.80
+73.51%
1.62
+16.68%
1.39
Gross Profit
21.40
+61.78%
13.23
+89.59%
6.98
+71.57%
4.07
Operating Expense
33.56
+3.27%
32.49
+8.86%
29.85
+23.81%
24.11
Research And Development
2.36
-55.65%
5.32
-3.61%
5.52
+117.67%
2.54
Selling General And Administration
31.20
+14.81%
27.17
+11.69%
24.33
+12.78%
21.57
Total Expenses
37.34
+5.79%
35.30
+12.18%
31.47
+23.43%
25.49
Operating Income
-12.16
+36.88%
-19.27
+15.76%
-22.87
-14.12%
-20.04
Total Operating Income As Reported
-12.16
+36.88%
-19.27
+15.76%
-22.87
-14.12%
-20.04
EBITDA
-10.90
+40.23%
-18.24
+18.11%
-22.28
-13.31%
-19.66
Normalized EBITDA
-10.90
+40.23%
-18.24
+18.11%
-22.28
-2.99%
-21.63
Reconciled Depreciation
1.26
+22.73%
1.02
+71.98%
0.60
+56.02%
0.38
EBIT
-12.16
+36.88%
-19.27
+15.76%
-22.87
-14.12%
-20.04
Total Unusual Items
—
—
0.00
-100.00%
1.97
Total Unusual Items Excluding Goodwill
—
—
0.00
-100.00%
1.97
Special Income Charges
—
—
0.00
-100.00%
1.97
Other Special Charges
—
—
—
-1.42
Restructuring And Mergern Acquisition
—
—
—
0.00
Net Income
-11.89
+36.89%
-18.83
+15.02%
-22.16
-28.71%
-17.22
Pretax Income
-11.98
+37.02%
-19.02
+15.81%
-22.59
-25.04%
-18.07
Net Non Operating Interest Income Expense
0.57
+32.10%
0.43
+50.87%
0.29
+2509.09%
0.01
Net Interest Income
0.57
+32.10%
0.43
+50.87%
0.29
+2509.09%
0.01
Interest Income Non Operating
0.57
+32.10%
0.43
+50.87%
0.29
+2509.09%
0.01
Interest Income
0.57
+32.10%
0.43
+50.87%
0.29
+2509.09%
0.01
Other Income Expense
-0.39
-111.41%
-0.18
-2966.67%
-0.01
-100.31%
1.96
Other Non Operating Income Expenses
-0.39
-111.41%
-0.18
-2966.67%
-0.01
+25.00%
-0.01
Gain On Sale Of Business
—
—
0.00
-100.00%
0.55
Tax Provision
-0.09
+50.00%
-0.19
+56.84%
-0.43
+49.35%
-0.85
Tax Rate For Calcs
0.00
-20.00%
0.00
-47.58%
0.00
-59.41%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
-100.00%
0.09
Net Income Including Noncontrolling Interests
-11.89
+36.89%
-18.83
+15.02%
-22.16
-28.71%
-17.22
Net Income From Continuing Operation Net Minority Interest
-11.89
+36.89%
-18.83
+15.02%
-22.16
-28.71%
-17.22
Net Income From Continuing And Discontinued Operation
-11.89
+36.89%
-18.83
+15.02%
-22.16
-28.71%
-17.22
Net Income Continuous Operations
-11.89
+36.89%
-18.83
+15.02%
-22.16
-28.71%
-17.22
Normalized Income
-11.89
+36.89%
-18.83
+15.02%
-22.16
-16.05%
-19.10
Net Income Common Stockholders
-11.89
+36.89%
-18.83
+15.02%
-22.16
-28.71%
-17.22
Diluted EPS
-1.59
+53.51%
-3.42
+27.12%
-4.69
-7.87%
-4.35
Basic EPS
-1.59
+53.51%
-3.42
+27.12%
-4.69
-7.87%
-4.35
Basic Average Shares
7.48
+35.68%
5.51
+16.68%
4.73
+19.81%
3.95
Diluted Average Shares
7.48
+35.68%
5.51
+16.68%
4.73
+19.81%
3.95
Diluted NI Availto Com Stockholders
-11.89
+36.89%
-18.83
+15.02%
-22.16
-28.71%
-17.22
Earnings From Equity Interest
—
—
—
0.55
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
20.47
+27.13%
16.10
-34.96%
24.76
-42.20%
42.83
Current Assets
16.30
+14.03%
14.29
-32.49%
21.17
-43.60%
37.54
Cash Cash Equivalents And Short Term Investments
11.97
+15.86%
10.33
-41.67%
17.71
-48.94%
34.69
Cash And Cash Equivalents
3.45
-66.61%
10.33
-41.67%
17.71
-48.94%
34.69
Other Short Term Investments
8.52
0.00
—
0.00
Receivables
1.37
+90.66%
0.72
+78.80%
0.40
-8.45%
0.44
Accounts Receivable
1.37
+90.66%
0.72
+78.80%
0.40
-8.45%
0.44
Inventory
1.68
-22.41%
2.16
+9.31%
1.98
+45.19%
1.36
Raw Materials
0.92
+10.94%
0.83
-1.42%
0.84
+9.75%
0.77
Work In Process
0.19
-87.45%
1.54
+97.43%
0.78
-80.87%
4.07
Finished Goods
0.56
+41.06%
0.40
+12.46%
0.35
-23.43%
0.46
Prepaid Assets
—
—
—
1.05
Restricted Cash
0.25
+0.00%
0.25
+0.00%
0.25
0.00
Other Current Assets
1.04
+24.16%
0.84
+0.24%
0.83
-20.80%
1.05
Total Non Current Assets
4.17
+130.70%
1.81
-49.54%
3.58
-32.29%
5.29
Net PPE
3.90
+451.98%
0.71
+14.80%
0.61
-19.08%
0.76
Gross PPE
3.90
+451.98%
0.71
+14.80%
0.61
-19.08%
0.76
Other Properties
3.90
+451.98%
0.71
+14.80%
0.61
-19.08%
0.76
Other Non Current Assets
0.27
-75.14%
1.10
-62.87%
2.97
-34.51%
4.53
Total Liabilities Net Minority Interest
12.93
+49.27%
8.66
+12.91%
7.67
+24.01%
6.18
Current Liabilities
9.15
+12.67%
8.12
+15.30%
7.04
+28.44%
5.49
Payables And Accrued Expenses
4.83
+3.65%
4.66
+15.03%
4.05
+86.85%
2.17
Payables
2.21
-9.28%
2.44
+7.65%
2.26
+88.34%
1.20
Accounts Payable
1.83
-15.53%
2.16
+1.60%
2.13
+126.97%
0.94
Current Accrued Expenses
2.62
+17.80%
2.23
+24.37%
1.79
+85.01%
0.97
Pensionand Other Post Retirement Benefit Plans Current
3.67
+23.05%
2.98
+15.68%
2.58
-11.45%
2.91
Total Tax Payable
0.38
+40.44%
0.27
+104.51%
0.13
-49.43%
0.26
Current Debt And Capital Lease Obligation
0.36
+305.62%
0.09
+20.27%
0.07
+21.31%
0.06
Current Capital Lease Obligation
0.36
+305.62%
0.09
+20.27%
0.07
+21.31%
0.06
Current Deferred Liabilities
0.08
-68.16%
0.24
+61.18%
0.15
0.00
Current Deferred Revenue
0.08
-68.16%
0.24
+61.18%
0.15
0.00
Other Current Liabilities
0.22
+44.97%
0.15
-22.40%
0.19
-44.67%
0.35
Total Non Current Liabilities Net Minority Interest
3.77
+602.98%
0.54
-14.08%
0.62
-10.71%
0.70
Long Term Debt And Capital Lease Obligation
3.77
+602.98%
0.54
-14.08%
0.62
-10.71%
0.70
Long Term Capital Lease Obligation
3.77
+602.98%
0.54
-14.08%
0.62
-10.71%
0.70
Stockholders Equity
7.54
+1.37%
7.44
-56.44%
17.09
-53.38%
36.65
Common Stock Equity
7.54
+1.37%
7.44
-56.44%
17.09
-53.38%
36.65
Capital Stock
0.01
+16.67%
0.01
+20.00%
0.01
+0.00%
0.01
Common Stock
0.01
+16.67%
0.01
+20.00%
0.01
+0.00%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
6.65
+10.80%
6.00
+26.51%
4.74
+0.66%
4.71
Ordinary Shares Number
6.65
+10.80%
6.00
+26.51%
4.74
+0.66%
4.71
Additional Paid In Capital
184.51
+6.84%
172.70
+5.62%
163.52
+1.67%
160.84
Retained Earnings
-177.09
-7.19%
-165.20
-12.87%
-146.37
-17.84%
-124.21
Gains Losses Not Affecting Retained Earnings
0.11
+278.13%
-0.06
+7.25%
-0.07
-630.77%
0.01
Minority Interest
—
—
—
0.00
Other Equity Adjustments
0.11
+278.13%
-0.06
+7.25%
-0.07
-630.77%
0.01
Total Equity Gross Minority Interest
7.54
+1.37%
7.44
-56.44%
17.09
-53.38%
36.65
Total Capitalization
7.54
+1.37%
7.44
-56.44%
17.09
-53.38%
36.65
Working Capital
7.15
+15.83%
6.17
-56.32%
14.13
-55.93%
32.06
Invested Capital
7.54
+1.37%
7.44
-56.44%
17.09
-53.38%
36.65
Total Debt
4.14
+560.70%
0.63
-10.44%
0.70
-8.15%
0.76
Capital Lease Obligations
4.14
+560.70%
0.63
-10.44%
0.70
-8.15%
0.76
Net Tangible Assets
7.54
+1.37%
7.44
-56.44%
17.09
-53.38%
36.65
Tangible Book Value
7.54
+1.37%
7.44
-56.44%
17.09
-53.38%
36.65
Inventories Adjustments Allowances
—
-0.61
+72.33%
-2.19
+44.33%
-3.94
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-6.95
+52.63%
-14.67
+11.88%
-16.64
-22.15%
-13.63
Cash Flow From Continuing Operating Activities
-6.95
+52.63%
-14.67
+11.88%
-16.64
-22.15%
-13.63
Net Income From Continuing Operations
-11.89
+36.89%
-18.83
+15.02%
-22.16
-28.71%
-17.22
Depreciation Amortization Depletion
1.26
+22.73%
1.02
+71.98%
0.60
+56.02%
0.38
Depreciation
1.26
+22.73%
1.02
+71.98%
0.60
—
Depreciation And Amortization
1.26
+22.73%
1.02
+71.98%
0.60
+56.02%
0.38
Other Non Cash Items
—
—
0.05
+536.36%
-0.01
Stock Based Compensation
1.87
+10.13%
1.70
-36.69%
2.68
-18.78%
3.30
Provisionand Write Offof Assets
0.05
-91.88%
0.63
+220.41%
0.20
+64.71%
0.12
Asset Impairment Charge
—
—
—
0.00
Operating Gains Losses
—
—
—
-1.97
Change In Working Capital
1.76
+115.83%
0.81
-60.11%
2.04
+25.49%
1.63
Change In Receivables
-0.71
-170.99%
-0.26
-808.11%
0.04
+117.05%
-0.22
Changes In Account Receivables
-0.71
-170.99%
-0.26
-808.11%
0.04
+117.05%
-0.22
Change In Inventory
0.71
+642.71%
0.10
-67.57%
0.30
-20.22%
0.37
Change In Prepaid Assets
0.10
+1375.00%
-0.01
-103.56%
0.23
-68.58%
0.72
Change In Payables And Accrued Expense
1.88
+76.93%
1.06
-31.35%
1.55
+74.02%
0.89
Change In Accrued Expense
0.83
-19.08%
1.03
+188.48%
0.36
-16.24%
0.42
Change In Payable
1.05
+2894.29%
0.04
-97.06%
1.19
+156.68%
0.46
Change In Account Payable
1.05
+2894.29%
0.04
-97.06%
1.19
+156.68%
0.46
Change In Other Current Assets
—
—
0.00
+100.00%
-0.15
Change In Other Current Liabilities
-0.23
-208.22%
-0.07
-17.74%
-0.06
-410.00%
0.02
Investing Cash Flow
-8.52
-4035.44%
-0.21
0.00
-100.00%
18.22
Cash Flow From Continuing Investing Activities
-8.52
-4035.44%
-0.21
0.00
-100.00%
18.22
Net PPE Purchase And Sale
0.00
+100.00%
-0.21
0.00
—
Purchase Of PPE
0.00
+100.00%
-0.21
0.00
—
Capital Expenditure
—
-0.21
—
—
Net Investment Purchase And Sale
-8.52
0.00
0.00
-100.00%
18.22
Purchase Of Investment
-8.52
0.00
0.00
+100.00%
-5.08
Sale Of Investment
—
—
0.00
-100.00%
23.30
Gain Loss On Sale Of Business
—
—
0.00
+100.00%
-0.55
Financing Cash Flow
8.44
+12.72%
7.49
0.00
-100.00%
25.68
Cash Flow From Continuing Financing Activities
8.44
+12.72%
7.49
0.00
-100.00%
25.68
Net Issuance Payments Of Debt
—
—
—
0.00
Issuance Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
8.30
+1.92%
8.14
0.00
-100.00%
25.68
Cash Dividends Paid
—
0.00
0.00
—
Proceeds From Stock Option Exercised
0.37
0.00
—
—
Net Other Financing Charges
-0.23
+64.69%
-0.66
—
—
Changes In Cash
-7.03
+4.86%
-7.39
+55.62%
-16.64
-154.98%
30.27
Effect Of Exchange Rate Changes
0.15
+2350.00%
0.01
+107.32%
-0.08
-146.86%
0.17
Beginning Cash Position
10.58
-41.09%
17.96
-48.22%
34.69
+717.75%
4.24
End Cash Position
3.70
-65.03%
10.58
-41.09%
17.96
-48.22%
34.69
Free Cash Flow
-6.95
+53.29%
-14.87
+10.64%
-16.64
-22.15%
-13.63
Interest Paid Supplemental Data
0.01
+0.00%
0.01
+116.67%
0.01
-40.00%
0.01
Income Tax Paid Supplemental Data
—
—
0.00
-100.00%
0.04
Amortization Of Securities
—
—
0.00
-100.00%
0.14
Common Stock Issuance
8.30
+1.92%
8.14
0.00
-100.00%
25.68
Interest Paid CFF
—
-0.66
0.00
—
Issuance Of Capital Stock
8.30
+1.92%
8.14
0.00
-100.00%
25.68
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category